|Articles|March 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Aciphex

Eisai Inc (Teaneck, NJ) recentlyannounced that it has assumed US distributionresponsibilities for Aciphex(rabeprazole sodium) from JanssenPharmaceutica Inc affiliate JOMPharmaceutical Services. Eisai andJanssen will continue to co-promoteAciphex, a proton pump inhibitor prescribedfor gastro-esophageal reflux disease(GERD). Eisai is fulfilling purchaseorders for Aciphex from a contract distributioncenter in Memphis, Tenn.The productis indicated for the treatment of symptomaticGERD, healing of erosive GERD,and maintenance of healed erosiveGERD. Aciphex also is approved as partof the first 7-day treatment forHelicobacter pylori infections, the singlemost common cause of peptic ulcers. Formore information, visit www.aciphex.com,or call 888-4ACIPHEX (888-422-4743).

Articles in this issue

over 21 years ago

New Technologies Top Survey

over 21 years ago

PDX Software Gets High Marks

over 21 years ago

Seal•ON

over 21 years ago

SaltAire Sinus Relief

over 21 years ago

Zim's Crack Creme Hand Sanitizer

over 21 years ago

CoroWise Plant Sterols

over 21 years ago

Culturelle

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME